Sakura Clinic
Gene therapy used in combination with standard treatment to prevent cancer recurrence, cancer metastasis, recurrence prevention, and metastasis In order to face the disease "cancer", it is extremely important to prevent cancer recurrence. Cancer treatment is based on the three main standard treatments: surgery, chemistry, and radiation. Standard treatments have made remarkable progress, and survival rates and quality of life have improved compared to before. It is a medical treatment that has been evaluated for its effectiveness. However, standard treatment is unlikely to prevent recurrence and metastasis. Sakura Clinic Medical Corporation Sakura Shinkai is working to popularize cancer gene therapy and cancer recurrence prevention in order to support patients and their families.
head doctor
Osamu Yoshida
career
1986 Graduated from Kyorin University School of Medicine
Department of Gastrointestinal Surgery, Kyorin University Hospital
1988 Tokyo Teishin Hospital, Department of Gastrointestinal Surgery (Thoracic Vascular Surgery)
1993 Respiratory and gastrointestinal surgery, Kyorin University Hospital
2010 Sakura Clinic opened for stem cell therapy and cancer immunotherapy Working on cancer gene therapy.
address
3F Shibuya KI Building, 1-16-9 Shibuya, Shibuya-ku, Tokyo 150-0002
medical item
cancer gene therapy
Cancer recurrence prevention treatment
stem cell therapy
Introduced a quality control system at our own CPC
Establishing a cell culture operation management system
SCT Special Plan
Regular menu
Number of cultured stem cells: around 200 million
Number of infusions: Twice a year for around 100 million cells
Price: 3 million yen
SCT special menu
Number of cultured stem cells: around 450 million
Number of infusions: Twice a year for around 220 million cells or more
Price: 8 million yen
SCT price 4 million yen